These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 21088899)

  • 1. IL-10 and TGF-β2 are overexpressed in tumor spheres cultured from human gliomas.
    Qiu B; Zhang D; Wang C; Tao J; Tie X; Qiao Y; Xu K; Wang Y; Wu A
    Mol Biol Rep; 2011 Jun; 38(5):3585-91. PubMed ID: 21088899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The CD133+ tumor stem-like cell-associated antigen may elicit highly intense immune responses against human malignant glioma.
    Hua W; Yao Y; Chu Y; Zhong P; Sheng X; Xiao B; Wu J; Yang B; Mao Y; Zhou L
    J Neurooncol; 2011 Nov; 105(2):149-57. PubMed ID: 21479962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glial progenitor-like phenotype in low-grade glioma and enhanced CD133-expression and neuronal lineage differentiation potential in high-grade glioma.
    Rebetz J; Tian D; Persson A; Widegren B; Salford LG; Englund E; Gisselsson D; Fan X
    PLoS One; 2008 Apr; 3(4):e1936. PubMed ID: 18398462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Presence of pluripotent CD133+ cells correlates with malignancy of gliomas.
    Thon N; Damianoff K; Hegermann J; Grau S; Krebs B; Schnell O; Tonn JC; Goldbrunner R
    Mol Cell Neurosci; 2010 Jan; 43(1):51-9. PubMed ID: 18761091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of NANOG in human gliomas and its relationship with undifferentiated glioma cells.
    Niu CS; Li DX; Liu YH; Fu XM; Tang SF; Li J
    Oncol Rep; 2011 Sep; 26(3):593-601. PubMed ID: 21573506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD90 is identified as a candidate marker for cancer stem cells in primary high-grade gliomas using tissue microarrays.
    He J; Liu Y; Zhu T; Zhu J; Dimeco F; Vescovi AL; Heth JA; Muraszko KM; Fan X; Lubman DM
    Mol Cell Proteomics; 2012 Jun; 11(6):M111.010744. PubMed ID: 22203689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-6 is overexpressed and augments invasiveness of human glioma stem cells in vitro.
    Qiu B; Zhang D; Wang Y; Ou S; Wang J; Tao J; Wang Y
    Clin Exp Metastasis; 2013 Dec; 30(8):1009-18. PubMed ID: 23832741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Chemoresistance of CD133(+) tumor stem cells from human brain glioma].
    Bi CL; Fang JS; Chen FH; Wang YJ; Wu J
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2007 Aug; 32(4):568-73. PubMed ID: 17767043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. B7-H4 expression is elevated in human U251 glioma stem-like cells and is inducible in monocytes cultured with U251 stem-like cell conditioned medium.
    Mo LJ; Ye HX; Mao Y; Yao Y; Zhang JM
    Chin J Cancer; 2013 Dec; 32(12):653-60. PubMed ID: 23327799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Temozolomide decreases invasion of glioma stem cells by down-regulating TGF-β2.
    Zhang D; Jing Z; Qiu B; Wu A; Wang Y
    Oncol Rep; 2011 Oct; 26(4):901-8. PubMed ID: 21725605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD133+ and nestin+ tumor-initiating cells dominate in N29 and N32 experimental gliomas.
    Bexell D; Gunnarsson S; Siesjö P; Bengzon J; Darabi A
    Int J Cancer; 2009 Jul; 125(1):15-22. PubMed ID: 19291792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of CD133 promotes drug resistance in C6 glioma cells.
    Angelastro JM; Lamé MW
    Mol Cancer Res; 2010 Aug; 8(8):1105-15. PubMed ID: 20663862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response.
    Bao S; Wu Q; McLendon RE; Hao Y; Shi Q; Hjelmeland AB; Dewhirst MW; Bigner DD; Rich JN
    Nature; 2006 Dec; 444(7120):756-60. PubMed ID: 17051156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. B7-H1 is correlated with malignancy-grade gliomas but is not expressed exclusively on tumor stem-like cells.
    Yao Y; Tao R; Wang X; Wang Y; Mao Y; Zhou LF
    Neuro Oncol; 2009 Dec; 11(6):757-66. PubMed ID: 19264916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Study on the proliferation and drug-resistance of human brain tumor stem-like cells.
    Qin K; Jiang X; Zou Y; Wang J; Qin L; Zeng Y
    Cell Mol Neurobiol; 2010 Aug; 30(6):955-60. PubMed ID: 20526804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Preliminary interpretation on the relationship between the phenotype of CD133+ cells and niche in transplanted human glioma in mice].
    Song WC; Fei XF; Dong J
    Zhonghua Zhong Liu Za Zhi; 2010 Aug; 32(8):564-9. PubMed ID: 21122405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of A2B5+CD133- tumor-initiating cells in adult human gliomas.
    Ogden AT; Waziri AE; Lochhead RA; Fusco D; Lopez K; Ellis JA; Kang J; Assanah M; McKhann GM; Sisti MB; McCormick PC; Canoll P; Bruce JN
    Neurosurgery; 2008 Feb; 62(2):505-14; discussion 514-5. PubMed ID: 18382330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prognostic value of clinical factors and cancer stem cell-related markers in gliomas.
    Dahlrot RH
    Dan Med J; 2014 Oct; 61(10):B4944. PubMed ID: 25283629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD133 Expression Is Not Synonymous to Immunoreactivity for AC133 and Fluctuates throughout the Cell Cycle in Glioma Stem-Like Cells.
    Barrantes-Freer A; Renovanz M; Eich M; Braukmann A; Sprang B; Spirin P; Pardo LA; Giese A; Kim EL
    PLoS One; 2015; 10(6):e0130519. PubMed ID: 26086074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Limits of CD133 as a marker of glioma self-renewing cells.
    Clément V; Dutoit V; Marino D; Dietrich PY; Radovanovic I
    Int J Cancer; 2009 Jul; 125(1):244-8. PubMed ID: 19350631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.